| 000 | 01365 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515161146.0 | ||
| 264 | 0 | _c20090605 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a1879-0410 | ||
| 024 | 7 |
_a10.1016/j.ceb.2009.01.016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLane, Heidi A | |
| 245 | 0 | 0 |
_aOptimal targeting of the mTORC1 kinase in human cancer. _h[electronic resource] |
| 260 |
_bCurrent opinion in cell biology _cApr 2009 |
||
| 300 |
_a219-29 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMechanistic Target of Rapamycin Complex 1 |
| 650 | 0 | 4 | _aMultiprotein Complexes |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aProteins |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xphysiology |
| 650 | 0 | 4 | _aTOR Serine-Threonine Kinases |
| 650 | 0 | 4 |
_aTranscription Factors _xantagonists & inhibitors |
| 700 | 1 | _aBreuleux, Madlaina | |
| 773 | 0 |
_tCurrent opinion in cell biology _gvol. 21 _gno. 2 _gp. 219-29 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ceb.2009.01.016 _zAvailable from publisher's website |
| 999 |
_c18676011 _d18676011 |
||